Abstract
Kawasaki disease (KD) is a vasculitis affecting the coronary and systemic arteries. Myocardial inflammation is also a common finding in KD post-mortem evaluation during the acute phase of the disease. Coronary artery aneurysms (CAAs) develop in 15–25 % of untreated children. Although 50–70 % of CAAs resolve spontaneously 1–2 years after the onset of KD, the remaining unresolved CAAs can develop stenotic lesions at either their proximal or distal end and can develop thrombus formation leading to ischemia and/or infarction. Cardiovascular magnetic resonance (CMR) has the ability to perform non-invasive and radiation-free evaluation of the coronary artery lumen. Recently tissue characterization of the coronary vessel wall was provided by CMR. It can also image myocardial inflammation, ischemia and fibrosis. Therefore CMR offers important clinical information during the acute and chronic phase of KD. In the acute phase, it can identify myocardial inflammation, microvascular disease, myocardial infarction, deterioration of left ventricular function, changes of the coronary artery lumen and changes of the coronary artery vessel wall. During the chronic phase, CMR imaging might be of value for risk stratification and to guide treatment.
Similar content being viewed by others
Notes
Kim and Goo [75].
References
Taubert KA, Rowley AH, Shulman ST (1994) Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 13:704–708
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733
Naoe S, Takahashi K, Masuda H, Tanaka N (1991) Kawasaki disease: with particular emphasis on arterial lesions. Acta Pathol Jpn 41:785–797
Yoshikawa H, NomuraY Y, Masuda K, Hazeki D, Yotsumoto K, Arata M, Kamenosono A, Yanagi S, Yoshinaga M, Kawano Y (2006) Four cases of Kawasaki syndrome complicated with myocarditis. Circ J 70:202–205
Shinohara T, Yokoyama T (1999) Clinical study of cardiac pump failure in acute phase of Kawasaki disease. J Pediatr Pract 62:2101–2104
Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Varlamis G, Kolovou G, Douskou M, Papadopoulos G (2011) Cardiovascular magnetic resonance evaluation of cardiac involvement during the convalescence phase of Kawasaki disease. JACC Cardiovasc Imag 4(10):1140–1141
Porcalla AR, Sable CA, Patel KM, Martin GR, Singh N (2005) The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms? Pediatr Cardiol 26:775–781
Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689–694
Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H (1992) Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet 340:1127–1129
Burns JC, Gordon JB, Malhora A, Schoenwetter M, Kawasaki T (1996) Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 28:253–257
Capannari TE, Daniels SR, Meyer RA, Schwartz DC, Kaplan S (1986) Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 7:355–360
Hiraishi S, Misawa H, Takeda N, Horiguchi Y, Fujino N, Ogawa N, Hirota H (2000) Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease. Heart 83:400–405
Albro PC, Gould KL, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL (1978) Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. Am J Cardiol 42:751–760
Mason JR, Palac RT, Freeman ML, Virupannavar S, Loeb HS, Kaplan E, Gunnar RM (1984) Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. Am Heart J 107:481–485
Kondo C, Hiroe M, Nakanishi T, Takao A (1989) Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201TI myocardial tomography. Circulation 80:615–624
Bergersen L, Gauvreau K, Marshall A, Kreutzer J, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K (2011) Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv 4:188–194
Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, Nikolaidou P, Bakoula C, Karanasios E, Manginas A, Cokkinos DV (2004) Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of the coronary arteries in Kawasaki disease. J Am Coll Cardiol 43:649–652
Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, Manning WJ, Powell AJ (2002) Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 105(8):908–911
Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, Langerak SE, Weber OM, Pedersen EM, Schmidt M, Botnar RM, Manning WJ (2001) Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 345:1863–1869
Post JC, van Rossum AC, Bronzwaer JG, de Cock CC, Hofman MB, Valk J, Visser CA (1995) Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 92:3163–3171
Lee DC, Simonetti OP, Harris KR, Holly TA, Judd RM, Wu E, Klocke FJ (2004) Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation 110:58–65
Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361:374–379
Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379(9814):453–460
Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453
Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV (2008) How to image Kawasaki disease: a validation of different imaging techniques. Int J Cardiol 124(1):27–31
Greil GF, Seeger A, Miller S, Claussen CD, Hofbeck M, Botnar RM, Sieverding L (2007) Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Pediatr Radiol 37(7):666–673
Uribe S, Hussain T, Valverde I, Tejos C, Irarrazaval P, Fava M, Beerbaum P, Botnar RM, Razavi R, Schaeffter T, Greil GF (2011) Congenital heart disease in children: coronary MR angiography during systole and diastole with dual cardiac phase whole-heart imaging. Radiology 260:232–240
Pedersen SF, Thrysøe SA, Paaske WP, Thim T, Falk E, Ringgaard S, Kim WY (2011) Determination of oedema in porcine coronary arteries by T2 weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 13:52
Tangcharoen T, Bell A, Hegde S, Hussain T, Beerbaum P, Schaeffter T, Razavi R, Botnar RM, Greil GF (2011) Detection of coronary artery anomalies in infants and young children with congenital heart disease by using MR imaging. Radiology 259:240–247
Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Varlamis G, Karanasios E, Krikos X, Giannoulia A, Cokkinos DV (2006) Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson 8(3):493–498
Halliburton S, Arbab-Zadeh A, Dey D, Einstein AJ, Gentry R, George RT, Gerber T, Mahesh M, Weigold WG (2012) State-of-the-art in ct hardware and scan modes for cardiovascular CT. J Cardiovasc Comput Tomogr 6:154–163
Han BK, Lindberg J, Grant K, Schwartz RS, Lesser JR (2011) Accuracy and safety of high pitch computed tomography imaging in young children with complex congenital heart disease. Am J Cardiol 107:1541–1546
Harada M, Yokouchi Y, Oharaseki T, Matsui K, Tobayama H, Tanaka N, Akimoto K, Takahashi K, Kishiro M, Shimizu T, Takahashi K (2012) Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology 61(6):1156–1167
Mavrogeni S, Spargias K, Markussis V, Kolovou G, Demerouti E, Papadopoulou E, Stavridis G, Kaklamanis L, Douskou M, Constantoulakis P, Cokkinos DV (2009) Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm Allergy Drug Targets 8(5):390–397
Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815–1822
Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV (2009) Cardiovascular magnetic resonance imaging reveals myocardial inflammation and coronary artery ectasia during the acute phase of Kawasaki disease. Int J Cardiol 136(3):e51–e53
Itamura S, Kamada M, Nakagawa N (2011) Kawasaki disease complicated with reversible splenial lesion and acute myocarditis. Pediatr Cardiol 32(5):696–699
Cunha BA, Pherez FM, Alexiadis V, Gagos M, Strollo S (2010) Adult Kawasaki’s disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels. Heart Lung 39(2):164–172
Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, Kuijpers TW (2011) Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imag 4(6):712–720
Silvera S, Strach K, Bogaert J, Sommer T, Vignaux O (2011) Cardiomyopathies (hypertrophy and failure): what can offer cardiac magnetic resonance imaging? Presse Med 40(9 Pt 2):e425–e436
Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA (1995) Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92:1902–1910
Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002
Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36:1985–1991
Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. New Engl J Med 343:1445–1453
Kaandorp TA, Lamb HJ, Poldermans D, Viergever EP, Boersma E, van der Wall EE, de Roos A, Bax JJ (2007) Assessment of right ventricular infarction with contrast-enhanced magnetic resonance imaging. Coron Artery Dis 18:39–43
Kumar A, Abdel-Aty H, Kriedemann I, Schulz-Menger J, Gross CM, Dietz R, Friedrich MG (2006) Contrast enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 48:1969–1976
Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, Kwong RY (2007) Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 49:855–862
Wu YW, Tadamura E, Kanao S, Yamamuro M, Marui A, Komeda M, Toma M, Kimura T, Togashi K (2007) Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography. Int J Cardiovasc Imag 23(6):757–765
Kwong RY, Chan AK, Brown KA et al (2006) Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113:2733–2743
Sato Y, Matsumoto N, Komatsu S, Kunimasa T, Tani S, Imazeki T, Anazawa T, Kasamaki Y, Kunimoto S, Takahashi M, Saito S (2007) Coronary artery abnormalities after Kawasaki disease in an adult: depiction at whole heart coronary magnetic resonance angiography. Int J Cardiol 116(3):396–398
Yoon YE, Kitagawa K, Kato S, Ishida M, Nakajima H, Kurita T, Ito M, Sakuma H (2012) Prognostic value of coronary magnetic resonance angiography for prediction of cardiac events in patients with suspected coronary artery disease. J Am Coll Cardiol 60(22):2316–2322
Ibrahim T, Makowski MR, Jankauskas A, Maintz D, Karch M, Schachoff S, Manning WJ, Schömig A, Schwaiger M, Botnar RM (2009) Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imag 2(5):580–588
Kim WY, Stuber M, Börnert P, Kissinger KV, Manning WJ, Botnar RM (2002) Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 106(3):296–299
Doesch C, Seeger A, Doering J, Herdeg C, Burgstahler C, Claussen CD, Gawaz M, Miller S, May AE (2009) Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imag 2(4):424–433
Kramer C, Barkhausen J, Flamm S, Kim R, Nagel E (2008) Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustes task force on standardized protocols. J Cardiovasc Magn Reson 10:35
Luechinger R, Scwitter J (2008) CMR update. J Schwitter Switz 30–41
Kozerke S, Tsao J (2004) Reduced data acquisition methods in cardiac imaging. Top Magn Reson Imag 15:161–168
Rangamani S, Varghese J, Li L, Harvey L, Hammel JM, Fletcher SE, Duncan KF, Danford DA, Kutty S (2012) Safety of cardiac magnetic resonance and contrast angiography for neonates and small infants: a 10-year single-institution experience. Pediatr Radiol 42(11):1339–1346
Lockie T, Ishida M, Perera D, Chiribiri A, De Silva K, Kozerke S, Marber M, Nagel E, Rezavi R, Redwood S, Plein S (2011) High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 57:70–75
Hautvast GLTF, Chiribiri A, Lockie T, Breeuwer M, Nagel E, Plein S (2011) Quantitative analysis of transmural gradients in myocardial perfusion magnetic resonance images. Magn Res Med 66:1477–1487
Chiribiri A, Hautvast GLTF, Lockie T, Schuster A, Bigalke B, Olivotti L, Redwood SR, Breeuwer M, Plein S, Nagel E (2013) Quantitative analysis of transmural perfusion gradients by high-resolution magnetic resonance versus fractional flow reserve for the assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imag 6:600–609
Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, Simonetti OP (2009) T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11:56
Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, Raman SV (2011) Direct t2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imag 4(3):269–278
Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52:1574–1580
Ladd SC, Debatin JF, Stang A, Bromen K, Moebus S, Nuefer M, Gizewski E, Wanke I, Doerfler A, Ladd ME, Benemann J, Erbel R, Forsting M, Schmermund A, Jöckel KH (1035) Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patients. Eur Radiol 2007(17):1035–1045
Papini GD, Di Leo G, Tritella S, Nano G, Cotticelli B, Clemente C, Tealdi DG, Sardanelli F (2011) Evaluation of inflammatory status of atherosclerotic carotid plaque before thromboendarterectomy using delayed contrast-enhanced subtracted images after magnetic resonance angiography. Eur J Radiol 80(3):e373–e380
Cheng AS, Pegg TJ, Karamitsos TD, Searle N, Jerosch-Herold M, Choudhury RP, Banning AP, Neubauer S, Robson MD, Selvanayagam JB (2007) Cardiovascular magnetic resonance perfusion imaging at 3-Tesla for the detection of coronary artery disease: a comparison with 1.5-Tesla. J Am Coll Cardiol 49:2440–2449
Gutberlet M, Schwinge K, Freyhardt P, Spors B, Grothoff M, Denecke T, Lüdemann L, Noeske R, Niendorf T, Felix R (2005) Influence of high magnetic field strengths and parallel acquisition strategies on image quality in cardiac 2d cine magnetic resonance imaging: comparison of 1.5 t vs. 3.0 t. Eur Radiol 15:1586–1597
Lee HL, Shankaranarayanan A, Pohost GM, Nayak KS (2010) Improved coronary MR angiography using wideband steady state free precession at 3 Tesla with submillimeter resolution. J Magn Reson Imag 31(5):1224–1229
Liu X, Bi X, Huang J, Jerecic R, Carr J, Li D (2008) Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 t. Invest Radiol 43:663–668
Uribe S, Hussain T, Valverde I, Tejos C, Irarrazaval P, Fava M, Beerbaum P, Botnar RM, Razavi R, Schaeffter T, Greil GF (2011) Congenital heart disease in children: coronary MR angiography during systole and diastole with dual cardiac phase whole-heart imaging. Radiology 260(1):232–240
Chapon C, Lemaire L, Franconi F, Marescaux L, Legras P, Denizot B, Le Jeune JJ (2004) Assessment of myocardial viability in rats: evaluation of a new method using superparamagnetic iron oxide nanoparticles and Gd-DOTA at high magnetic field. Magn Reson Med 52(4):932–936
Wu YL, Ye Q, Sato K, Foley LM, Hitchens TK, Ho C (2009) Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance. JACC Cardiovasc Imag 2(6):731–741
Richards JM, Semple SI, MacGillivray TJ, Gray C, Langrish JP, Williams M, Dweck M, Wallace W, McKillop G, Chalmers RT, Garden OJ, Newby DE (2011) Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study. Circ Cardiovasc Imag 4(3):274–281
Kim JW, Goo HW (2013) Coronary artery abnormalities in Kawasaki disease: comparison between ct and mr coronary angiography. Acta Radiol 54:156–163
Acknowledgments
The Division of Imaging Sciences receives support from the Centre of Excellence in Medical Engineering (funded by the Wellcome Trust and the Engineering and Physical Sciences Research Council; grant WT 088641/Z/09/Z) as well as the British Heart Foundation Centre of Excellence (British Heart Foundation award RE/08/03). Further support is provided through the Medical Research Council (MRC) Centre for Transplantation, King’s College London, UK (MRC grant no. MR/J006742/1). This research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The authors thank James Otton, St Vincent’s Hospital Sydney, Australia, for his comments regarding the use of Computed Tomography for coronary imaging.
Conflict of interest
There is no conflict of Interest for any of authors of the review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mavrogeni, S., Papadopoulos, G., Hussain, T. et al. The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease. Int J Cardiovasc Imaging 29, 1787–1798 (2013). https://doi.org/10.1007/s10554-013-0276-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-013-0276-9